{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:04:14Z","timestamp":1762160654530},"reference-count":26,"publisher":"BMJ","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["British Journal of Ophthalmology"],"published-print":{"date-parts":[[1993,2,1]]},"DOI":"10.1136\/bjo.77.2.110","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T21:53:19Z","timestamp":1190152399000},"page":"110-114","source":"Crossref","is-referenced-by-count":27,"title":["The EP2 receptor is the predominant prostanoid receptor in the human ciliary muscle."],"prefix":"10.1136","volume":"77","author":[{"given":"T","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M S","family":"Cynader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","first-page":"1474","article-title":"The effect of prostaglandin F2alpha on intraocular pressure in normotensive human subjects","volume":"29","author":"Lee, P.Y.; Shao, H.; Xu, L.; Qu, C.K.","year":"1988","unstructured":"Lee PY, Shao H, Xu L, Qu CK. The effect of prostaglandin F2alpha on intraocular pressure in normotensive human subjects. Invest Ophthalmol Vis Sci 1988; 29: 1474-7.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/bjo.73.6.419","article-title":"Prostaglandin F2,, isopropylester eye drops: effects in normal human eyes","volume":"73","author":"Villumsen, J.; Alm, A.","year":"1989","unstructured":"Villumsen J, Alm A. Prostaglandin F2,, isopropylester eye drops: effects in normal human eyes. BrJ Ophthalmol 1989; 73:419-26.","journal-title":"BrJ Ophthalmol"},{"key":"ref_3","first-page":"1329","article-title":"Maintained reduction of intraocular pressure by prostaglandin F2alpha-l-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients","volume":"%:","author":"CamrasCB, Siebold E.C.; JS, Lustgarten; JB, Serle; SC, Frisch; SM, Podos","year":"1989","unstructured":"CamrasCB, Siebold EC, Lustgarten JS, Serle JB, Frisch SC, Podos SM, et al. Maintained reduction of intraocular pressure by prostaglandin F2alpha-l-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients. Ophthalmology 1989; %: 1329-37.","journal-title":"Ophthalmology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/bjo.73.12.975","article-title":"Prostaglandin F2,,-isopropylester eye drops: effect on intraocular pressure in open-angle glaucoma","volume":"73","author":"Villumsen, J.; Alm, A.; Soederstroem, M.","year":"1989","unstructured":"Villumsen J, Alm A, Soederstroem M. Prostaglandin F2,,-isopropylester eye drops: effect on intraocular pressure in open-angle glaucoma. BrJ Ophthalmol 1989; 73: 975-9.","journal-title":"BrJ Ophthalmol"},{"key":"ref_5","first-page":"588","article-title":"Comparison of the hypotensive and other ocular effects of prostaglandin E2 and F2alpha on cat and rhesus monkey eyes","volume":"22","author":"Stern, F.A.; Bito, L.Z.","year":"1982","unstructured":"Stern FA, Bito LZ. Comparison of the hypotensive and other ocular effects of prostaglandin E2 and F2alpha on cat and rhesus monkey eyes. Invest Ophthalmol Vis Sci 1982; 22: 588-98.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref_6","first-page":"312","article-title":"Long-term maintenance of reduced intraocular pressure by daily or twice daily topical application of prostaglandins to cat or rhesus monkey eyes","volume":"24","author":"Bito, L.Z.; Draga, A.; Blanco, J.; Camras, C.B.","year":"1983","unstructured":"Bito LZ, Draga A, Blanco J, Camras CB. Long-term maintenance of reduced intraocular pressure by daily or twice daily topical application of prostaglandins to cat or rhesus monkey eyes. Invest Ophthalmol VisSci 1983; 24: 312-9.","journal-title":"Invest Ophthalmol VisSci"},{"key":"ref_7","first-page":"376","article-title":"Noninvasive observations on eyes of cats after long-term maintenance of reduced intraocular pressure by topical application of prostaglandin E2","volume":"24","author":"Bito, L.Z.; Srinivasan, B.D.; Baroody, R.A.; Schubert, H.","year":"1983","unstructured":"Bito LZ, Srinivasan BD, Baroody RA, Schubert H. Noninvasive observations on eyes of cats after long-term maintenance of reduced intraocular pressure by topical application of prostaglandin E2. Invest Ophthalmol Vis Sci 1983; 24: 376-80.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0014-4835(84)90102-7","article-title":"Comparison of the ocular hypotensive efficacy of eicosanoids and related compounds","volume":"38","author":"Bito, L.Z.","year":"1984","unstructured":"Bito LZ. Comparison of the ocular hypotensive efficacy of eicosanoids and related compounds. Exp Eye Res 1984; 38: 181-94.","journal-title":"Exp Eye Res"},{"key":"ref_9","first-page":"461","article-title":"Hayaishi 0, Prostaglandin D2 reduces intraocular pressure","volume":"72","author":"Goh, Y.; Nakajima, M.; Azuma, I.","year":"1988","unstructured":"Goh Y, Nakajima M, Azuma I, Hayaishi 0, Prostaglandin D2 reduces intraocular pressure. BrJ Ophihalmol 1988; 72: 461-4.","journal-title":"BrJ Ophihalmol"},{"key":"ref_10","first-page":"138","article-title":"Studies on the ocular pharmacology of prostaglandin D2","volume":"31","author":"Woodward, D.F.; Hawley, S.B.; Williams, L.S.; Ralston, T.R.; Protzman, C.E.; Spada, C.S.","year":"1990","unstructured":"Woodward DF, Hawley SB, Williams LS, Ralston TR, Protzman CE, Spada CS, et al. Studies on the ocular pharmacology of prostaglandin D2. Invest Ophthalmol Vis Sci 1990; 31: 138-46.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref_11","first-page":"389","article-title":"Prostaglandin F2alpha increases uveoslceraloutflow in the cynomolgus monkey","volume":"49","author":"Gabelt, B.T.; Kaufman, P.L.","year":"1989","unstructured":"Gabelt BT, Kaufman PL. Prostaglandin F2alpha increases uveoslceraloutflow in the cynomolgus monkey. Exp EyeRes 1989; 49: 389-402.","journal-title":"Exp EyeRes"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0014-4835(89)90011-0","article-title":"Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2alpha-l-isopropylester in the cynomolgus monkey","volume":"48","author":"Nilsson, S.F.E.; Samuelsson, M.; Bill, A.; Stjernschantz, J.","year":"1989","unstructured":"Nilsson SFE, Samuelsson M, Bill A, Stjernschantz J. Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2alpha-l-isopropylester in the cynomolgus monkey. Exp Eye Res 1989; 48: 707-16.","journal-title":"Exp Eye Res"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1001\/archopht.1987.01060080114039","article-title":"Pilocarpine antagonizes prostaglandin F2alpha-induced ocular hypotension in monkeys. Evidence for enhancement of uveoscleral outflow by prostaglandin F2alpha","volume":"105","author":"Crawford, K.; Kaufman, P.L.","year":"1987","unstructured":"Crawford K, Kaufman PL. Pilocarpine antagonizes prostaglandin F2alpha-induced ocular hypotension in monkeys. Evidence for enhancement of uveoscleral outflow by prostaglandin F2alpha. Arch Ophthalmol 1987; 105: 1112-6.","journal-title":"Arch Ophthalmol"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/bjo.76.4.210","article-title":"Localisation of prostaglandin F2,, and E2 binding sites in the human eye","volume":"76","author":"Matsuo, T.; Cynader, M.S.","year":"1992","unstructured":"Matsuo T, Cynader MS. Localisation of prostaglandin F2,, and E2 binding sites in the human eye. BrJ7 Ophthalmol 1992; 76:210-3.","journal-title":"BrJ7 Ophthalmol"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0090-6980(82)90036-3","article-title":"Studies on the characterization of prostanoid receptors: a proposed classification","volume":"24","author":"Kennedy, I.; Coleman, R.A.; Humphrey, P.P.A.; Levy, G.P.; Lumley, P.","year":"1982","unstructured":"Kennedy I, Coleman RA, Humphrey PPA, Levy GP, Lumley P. Studies on the characterization of prostanoid receptors: a proposed classification. Prostaglandins 1982; 24: 667-89.","journal-title":"Prostaglandins"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0165-6147(84)90452-8","article-title":"Prostanoid receptors. The development of a working classification","volume":"5","author":"Coleman, R.A.; Humphrey, P.P.A.; Kennedy, I.; Lumley, P.","year":"1984","unstructured":"Coleman RA, Humphrey PPA, Kennedy I, Lumley P. Prostanoid receptors. The development of a working classification. Trends Pharmacol Sci 1984; 5: 303-6.","journal-title":"Trends Pharmacol Sci"},{"key":"ref_17","first-page":"1335","article-title":"Characterization of the prostanoid receptor profile of enprostil and isomers in smooth muscle and platelets in vitro","volume":"98","author":"Eglen, R.M.; Whiting, R.L.","year":"1989","unstructured":"Eglen RM, Whiting RL. Characterization of the prostanoid receptor profile of enprostil and isomers in smooth muscle and platelets in vitro. BrJPharmacol 1989; 98: 1335-43.","journal-title":"BrJPharmacol"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/349617a0","article-title":"Cloning and expression of cDNA for a human thromboxane A2 receptor","volume":"349","author":"Hirata, M.; Hayashi, Y.; Ushikubi, F.; Yokota, Y.; Kageyama, R.; Nakanishi, S.","year":"1991","unstructured":"Hirata M, Hayashi Y, Ushikubi F, Yokota Y, Kageyama R, Nakanishi S, et al. Cloning and expression of cDNA for a human thromboxane A2 receptor. Nature 1991; 349:617-20.","journal-title":"Nature"},{"key":"ref_19","first-page":"1109","article-title":"Prostaglandin E2 binding sites in bovine iris-ciliary body","volume":"31","author":"Bhattacherjee, P.; Csukas, S.; Paterson, C.A.","year":"1990","unstructured":"Bhattacherjee P, Csukas S, Paterson CA. Prostaglandin E2 binding sites in bovine iris-ciliary body. Invest Ophthalmol Vis Sci 1990; 31:1109-13.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0773.1989.tb01136.x","article-title":"Prostaglandin F2alpha binding to bovine ocular and synthetic melanins in vitro","volume":"65","author":"Aula, P.; Kaila, T.; Huupponen, R.; Salminen, L.; Iisalo, E.","year":"1989","unstructured":"Aula P, Kaila T, Huupponen R, Salminen L, Iisalo E. Prostaglandin F2alpha binding to bovine ocular and synthetic melanins in vitro. Pharmacol Toxicol 1989; 65: 100-3.","journal-title":"Pharmacol Toxicol"},{"key":"ref_21","first-page":"405","article-title":"Biochemical characterization and autoradiographic localization of [3H]PGE2 binding sites in rat kidney","volume":"139","author":"Eriksson, L.O.; Larsson, B.; Andersson, K.E.","year":"1990","unstructured":"Eriksson LO, Larsson B, Andersson KE. Biochemical characterization and autoradiographic localization of [3H]PGE2 binding sites in rat kidney. Acta PhysiolScand 1990; 139: 405-15.","journal-title":"Acta PhysiolScand"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"13570","DOI":"10.1016\/S0021-9258(18)33485-9","article-title":"Specific binding of prostaglandin D2 to rat brain synaptic membrane. Occurrence, properties, and distribution","volume":"257","year":"1982","unstructured":"Shimizu T, Yamashita A, Hayaishi 0. Specific binding of prostaglandin D2 to rat brain synaptic membrane. Occurrence, properties, and distribution. J Biol Chem 1982; 257: 13570-5.","journal-title":"J Biol Chem"},{"key":"ref_23","first-page":"1838","article-title":"Prostaglandin F2alpha effects on intraocular pressure negatively correlate with FP-receptor stimulation","volume":"30","author":"Woodward, D.F.; Burke, J.A.; Williams, L.S.; Palmer, B.P.; Wheeler, L.A.; Woldemussie, E.","year":"1989","unstructured":"Woodward DF, Burke JA, Williams LS, Palmer BP, Wheeler LA, Woldemussie E, et al. Prostaglandin F2alpha effects on intraocular pressure negatively correlate with FP-receptor stimulation. Invest Ophthalmol Vis Sci 1989; 30: 1838-42.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref_24","first-page":"2560","article-title":"EP3, but not EP2, FP, or TP prostanoid-receptor stimulation may reduce intraocular pressure","volume":"31","author":"Waterbury, L.D.; Eglen, R.M.; Faurot, G.F.; Cooper, G.F.","year":"1990","unstructured":"Waterbury LD, Eglen RM, Faurot GF, Cooper GF. EP3, but not EP2, FP, or TP prostanoid-receptor stimulation may reduce intraocular pressure. Invest Ophihalmol Vis Sci 1990; 31: 2560-7.","journal-title":"Invest Ophihalmol Vis Sci"},{"key":"ref_25","first-page":"870","article-title":"Comparison of the pharmacology of prostanoid induced ciliary muscle relaxation and ocular hypotension reveals a correlation. ARVO abstracts","volume":"1991","author":"Chen, J.; Protzman, C.E.; Woodward, D.F.","unstructured":"Chen J, Protzman CE, Woodward DF. Comparison of the pharmacology of prostanoid induced ciliary muscle relaxation and ocular hypotension reveals a correlation. ARVO abstracts. Supplement to Invest Ophthalmol Vis Sci. Philadelphia: Lippincott, 1991: 870.","journal-title":"Supplement to Invest Ophthalmol Vis Sci. Philadelphia: Lippincott"},{"key":"ref_26","first-page":"2463","article-title":"Prostanoid-induced blood-aqueous barrier breakdown in rabbits.nvolves the EP2 receptor subtype","volume":"31","author":"Protzman, C.E.; Woodward, D.F.","year":"1990","unstructured":"Protzman CE, Woodward DF. Prostanoid-induced blood-aqueous barrier breakdown in rabbits.nvolves the EP2 receptor subtype. Invest Ophthalmol Vis Sci 1990; 31: 2463-6.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo.77.2.110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T19:24:05Z","timestamp":1629746645000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo.77.2.110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,2,1]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1993,2,1]]}},"URL":"https:\/\/doi.org\/10.1136\/bjo.77.2.110","relation":{},"ISSN":["0007-1161"],"issn-type":[{"value":"0007-1161","type":"print"}],"subject":[],"published":{"date-parts":[[1993,2,1]]}}}